January 2026 Options Now Available For Gilead Sciences (GILD)

StockOptionsChannel highlights two Gilead Sciences (GILD) option strategies: selling the Jan‑2026 $112 put for a $1.17 bid would obligate purchase at $112 (effective cost basis $110.83 versus today’s $122.42), is ~9% out‑of‑the‑money with a current 79% probability of expiring worthless, and would yield a 1.04% return on cash (7.63% annualized) if it does. Alternatively, selling the Jan‑2026 $131 covered call for $1.12 against shares bought at $122.42 would cap upside at $131 but produce a 7.92% total return if called, is ~7% out‑of‑the‑money with a 71% chance of expiring worthless, and would add a 0.91% premium boost (6.68% annualized) if it does. Implied volatility is 36% on the put and 31% on the call versus a trailing 12‑month volatility of 28%; StockOptionsChannel will track probability and contract‑level charts over time, underscoring the tradeoff between yield enhancement and capped upside or share assignment.

Analysis

StockOptionsChannel outlines two Jan‑2026 option strategies for Gilead Sciences (GILD). Selling the $112 put at a $1.17 bid would obligate purchase at $112 with an effective cost basis of $110.83 versus today’s $122.42, the strike is ~9% out‑of‑the‑money and the modelled probability of the contract expiring worthless is 79%; that outcome yields 1.04% on the cash commitment or 7.63% annualized (before commissions).

Selling a covered call at the $131 strike for a $1.12 bid against stock bought at $122.42 caps proceeds at $131 but produces a 7.92% total return if called; the $131 strike is ~7% out‑of‑the‑money with a 71% chance of expiring worthless and the premium represents a 0.91% (6.68% annualized) YieldBoost if it does.

Implied volatility is richer than realized volatility (put IV 36%, call IV 31% vs trailing 12‑month volatility 28%), implying option premiums are elevated relative to historical movement. The trades enhance yield but carry assignment or capped‑upside risk; StockOptionsChannel’s probability charts are model‑based and should be monitored as inputs (price, IV, greeks) change.

Key Decisions for Investors

• Consider selling the Jan‑2026 $112 put only if you are comfortable owning GILD at an effective $110.83 and size positions to cover the cash commitment given the 79% modeled chance of expiry worthless
• If already long GILD, consider selling the Jan‑2026 $131 covered call to capture a 0.91% premium boost and potential 7.92% capped return while accepting forgone upside above $131
• Factor the IV premium (put 36% vs realized 28%) into trade sizing and prefer scaling in or shorter expirations if you want to reduce exposure to IV reversion
• Explicitly include broker commissions in yield calculations and set price/volatility alerts to revisit these positions as StockOptionsChannel updates the contract probability charts